Opioid use disorder continues to impact communities across the country, and expanding access to Medication Assisted Treatment (MAT) remains one of the most effective strategies for improving outcomes and saving lives. This session will examine the operational, clinical, regulatory, and financial considerations involved in scaling MAT programs across diverse care settings.
Industry leaders will discuss how organizations are overcoming barriers to access, integrating MAT into broader treatment services, leveraging partnerships with health systems and payers, and addressing stigma that can limit adoption and engagement. Attendees will learn how innovative treatment models, data-driven care strategies, and workforce development efforts are helping providers reach more individuals with evidence-based opioid use disorder treatment.